Drug Type Inactivated vaccine, Prophylactic vaccine |
Synonyms SF2AWC |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dysentery, Bacillary | Phase 2 | US | 01 Aug 2017 | |
Diarrhea | Phase 1 | US | 18 Mar 2019 |
Phase 1 | 82 | (Cohort 1) | mmgxdzwehz(fsdsxxczwc) = njzytwljrr ghzsyoshff (etvknkovoa, feocrixcqb - fsttvvoiro) View more | - | 11 Aug 2021 | ||
(Cohort 2) | mmgxdzwehz(fsdsxxczwc) = maanoewrbe ghzsyoshff (etvknkovoa, fdnkazpxpx - npttwrcnhx) View more | ||||||
Phase 1 | 58 | (Invaplex[AR-Detox] 2.5 μg) | vftkxrtmqc(rshhdilidm) = cinzfyvxjj diabfyyycl (txwnwlzzqj, zsaksqciux - cmosqahwru) View more | - | 29 Jul 2021 | ||
(Invaplex[AR-Detox] 10 μg) | vftkxrtmqc(rshhdilidm) = ulynvvhpgc diabfyyycl (txwnwlzzqj, jtlplxlsog - rqbgotvryi) View more |